Who owns UNICYCIVE THERAPEUTICS INC?
- Ticker: UNCY
- CUSIP Number: 90466y103
Tip: Access positions for across all investors
Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Unicycive Therapeutics stock
Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 3.6M | $5.0M | 71% | Mar 2024 |
|
RA Capital Management | 3.5M | $4.8M | 0% | Mar 2024 |
|
Vivo Capital | 3.5M | $4.8M | 0% | Mar 2024 |
|
Logos Global Management | 3.5M | $3.0M | 100% | Mar 2024 |
|
Nantahala Capital Management | 3.3M | $8.6M | -3% | Mar 2024 |
|
Rosalind Advisors | 1.9M | $2.6M | 100% | Mar 2024 |
|
Monashee Investment Management | 1.0M | $1.4M | 100% | Mar 2024 |
|
Vanguard Group | 340k | $469k | 195% | Mar 2024 |
|
Geode Capital Management | 253k | $349k | 383% | Mar 2024 |
|
Goldman Sachs Group | 93k | $129k | 0% | Mar 2024 |
|
Citadel Advisors | 69k | $96k | 96% | Mar 2024 |
|
Virtu Financial | 26k | $36k | 100% | Mar 2024 |
|
Northern Trust | 24k | $33k | 100% | Mar 2024 |
|
Captrust Financial Advisors | 19k | $26k | 0% | Mar 2024 |
|
Tandem Capital Management Corp | 16k | $21k | 0% | Mar 2024 |
|
Integrated Wealth Concepts | 10k | $14k | 100% | Mar 2024 |
|
Tower Research Capital | 7.7k | $11k | 150% | Mar 2024 |
|
UBS Group | 4.4k | $6.1k | 2393% | Mar 2024 |
|
Wells Fargo & Company | 196.00 | $270.009600 | 2% | Mar 2024 |
|
Jpmorgan Chase & Co | 47.00 | $65.001000 | 100% | Mar 2024 |
|
Who sold out of Unicycive Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Beacon Pointe Advisors | Sep 2023 | 12k | $10k |